Alpha 2.0
Login Register
» Authors » David Robbins

David Robbins

Explore the profile of David Robbins including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 1603
Followers 0
Related Specialties
Chemistry
Cell Biology
Biochemistry
Top 10 Co-Authors
Gisela Ferreira
Steven M Cramer
Thuy Le
Dennis T Villareal
Wai Keen Chung
Georgia Colleluori
Reina Armamento-Villareal
Clifford Qualls
Steven T Evans
Margaret R Karagas
Published In
J Chromatogr A
Biotechnol Prog
Biotechnol Bioeng
Stem Cell Reports
Am J Hum Biol
Affiliations
Soon will be listed here.
Recent Articles
1.
Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imaging
Parasido E, Ribeiro P, Chingle R, Rohwetter T, Gupta N, Avetian G, et al.
Cell Cycle . 2024 Jul; :1-12. PMID: 38984667
Colorectal cancer (CRC) is the third most common cancer worldwide. In the United States alone, CRC was responsible for approximately 52,550 deaths in 2023, with an estimated 153,020 new cases....
2.
Improved process intermediate stability through the identification and elimination of reactive glycation residues - a monoclonal antibody case study
Bosley A, Cook K, Lin S, Robbins D
Bioengineered . 2022 Jun; 13(6):14402-14412. PMID: 35757891
The manufacturing of therapeutic biologics can result in a heterogeneous population of charge variants, encompassing many quality attributes which could impact activity and pharmacokinetics. Monitoring the relative abundance of these...
3.
Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders
Ben Nasr M, Robbins D, Parone P, Usuelli V, Tacke R, Seelam A, et al.
J Immunol . 2022 Mar; 208(7):1554-1565. PMID: 35321879
Type 1 diabetes (T1D) is characterized by the loss of immune self-tolerance, resulting in an aberrant immune responses against self-tissue. A few therapeutics have been partially successful in reverting or...
4.
Demonstration and Evaluation of Physical Examination Techniques Intended to Identify Proximal Femoral Bone Stress Injuries
Thelen M, Sutlive T, Traygord B, Robbins D, Schiferl R, Brock B, et al.
Med J (Ft Sam Houst Tex) . 2021 Dec; (Per 22-01/02/03):66-73. PMID: 34940971
Purpose: Proximal femoral bone stress injuries (BSI), especially those involving the femoral neck (FNBSI), pose a risk to military medical readiness. There is currently no optimal physical examination technique or...
5.
Understanding the effects of system differences for parameter estimation and scale-up of high throughput chromatographic data
Keller W, Evans S, Ferreira G, Robbins D, Cramer S
J Chromatogr A . 2021 Dec; 1661:462696. PMID: 34875516
In this paper, we evaluate how employing fraction collection and multistep gradients with RoboColumns® (Repligen, formally Atoll) affects both comparison to benchtop experimental data and column simulation parameter estimation. These...
6.
Maternal gestational mercury exposure in relation to cord blood T cell alterations and placental gene expression signatures
Movassagh H, Halchenko Y, Sampath V, Nygaard U, Jackson B, Robbins D, et al.
Environ Res . 2021 Jun; 201:111385. PMID: 34129869
The immunotoxic impacts of mercury during early life is poorly understood. We investigated the associations between gestational mercury exposure and frequency of cord blood T cells as well as placental...
7.
Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential
Luo H, Li Y, Robbins D, Wang S, Xi G, Cox M, et al.
Biotechnol Prog . 2020 Dec; 37(3):e3119. PMID: 33373106
Process-related impurities (PRIs) derived from manufacturing process should be minimized in final drug product. ICH Q3A provides a regulatory road map for PRIs but excludes biologic drugs like monoclonal antibodies...
8.
Pressure-Flow experiments, packing, and modeling for scale-up of a mixed mode chromatography column for biopharmaceutical manufacturing
Prentice J, Evans S, Robbins D, Ferreira G
J Chromatogr A . 2020 Jul; 1625:461117. PMID: 32709364
To obtain consistent chromatographic behavior, it is important to develop resin packing methods in accordance with the characteristics of each resin. Resins, particularly those with a significant level of compressibility,...
9.
Guidance for resuming GI endoscopy and practice operations after the COVID-19 pandemic
Hennessy B, Vicari J, Bernstein B, Chapman F, Khaykis I, Littenberg G, et al.
Gastrointest Endosc . 2020 May; 92(3):743-747.e1. PMID: 32437712
No abstract available.
10.
Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
Jacobson L, Collins T, Lucas M, Zackula R, Okut H, Nazir N, et al.
Contemp Clin Trials Commun . 2020 Apr; 18:100565. PMID: 32346648
Background: Overweight and obesity are major risk factors for gestational diabetes among U.S. women. Evidence suggests that longer duration of breastfeeding among women with a history of gestational diabetes is...